The broad aim of this 5 year research study is to advance understanding
of the neurophysiological and biological bases of schizophrenia. The
first project proposed is a study of first episode psychotic patients and
matched normal controls. The major questions to be addressed are whether
the event-related potential (ERP) abnormalities we have found to
characterize chronic schizophrenics are present at first hospitalization,
without the confounds associated with chronicity. The major ERP paradigm
will be the auditory oddball P300, on which chronic schizophrenics have
shown both an overall amplitude reduction and a topographic abnormality,
a left temporal scalp region amplitude reduction (left temporal feature,
LTF). We predict these abnormalities will be present at the first
episode and will differentiate those patients diagnosed as schizophrenic
on retest one year later vs. those with mood disorder or transient
psychosis. The importance of such potential diagnostic predictors is
evident. Other ERPs elicited in the oddball paradigm will also be
studied (Nl00, P200, N200), as will the N400. These ERPs provide
additional indices of information processing abnormalities and thus the
determination of their time of onset and prognostic value is also
important.
The second major project involves correlation of ERP abnormalities in
chronic schizophrenics with quantitative volumetric Magnetic Resonance
Imaging (MRI) definition of specific regions of interest (ROI) in
temporal and frontal lobe. This approach combines the strengths of a
technology with high time resolution and functional information (ERPs)
with one having a high spatial resolution (MRI). This project takes
advantage of the advanced imaging capabilities of the Brigham and Womens
Hospital MRI facility. It predicts quite specific sets of correlations
between abnormalities in ERPs and clinical features, and of volume
reduction in specific MRI ROI in schizophrenics, whereas matched normals
are expected to show no MRI-ERP correlations. The paradigmatic
prediction is an association between the P300 LTF/clinical thought
disorder and volume, reduction of the left posterior superior temporal
gyrus (STG) gray matter in right-handed subjects. Our working hypothesis
is that part of the pathophysiology of schizophrenic thought is explained
by 2 disturbance in the language/auditory -related cortical areas, and
that the P300 amplitude reduction reflects a disturbance of memory
updating that is dependent on the same brain regions. In left handed
subjects we predict the P300 amplitude reduction in the right temporal
scalp region will correlate with reduced volume in the right posterior
STG; this association with hand dominance may reflect abnormalities
associated with schizophrenic hemispheric specialization. Other ERP-MRI
associations may also provide clues as to which abnormal brain regions
are responsible for abnormalities of information processing.
Other components of the research program will examine the association of
ERP- and MRI-defined biological abnormalities with
neuropsychological/cognitive probes that complement the ERP probes. It
is predicted that disturbances of semantic memory and association will be
related to hippocampal-auditory association cortex while disturbances of
attention apparent in the Posner and computer-controlled Continuous
Performance Task will be associated with prefrontal cortex abnormalities,
especially on the left (in right-handed subjects) and especially in
middle and inferior frontal gyri gray matter.
No Sub Projects information available for 5R01MH040799-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01MH040799-09
Patents
No Patents information available for 5R01MH040799-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01MH040799-09
Clinical Studies
No Clinical Studies information available for 5R01MH040799-09
News and More
Related News Releases
No news release information available for 5R01MH040799-09
History
No Historical information available for 5R01MH040799-09
Similar Projects
No Similar Projects information available for 5R01MH040799-09